https://www.selleckchem.com/products/n6f11.html
Furthermore, the dynamic glucose monitoring data revealed that significantly affected blood glucose levels compared with that of healthy controls were observed at postprandial periods in the Cushing syndrome and primary aldosteronism groups; at nocturnal, fasting and postprandial periods in the pheochromocytoma group. Significant insulin resistance and abnormal β-cell function were observed in the Cushing syndrome group compared with that in healthy controls. Adrenal diseases can negatively affect glucose metabolism. Patients diagnosed wi
Like
Comment
Share
